KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Jazz Pharmaceuticals (JAZZ) Return on Assets (2016 - 2025)

Historic Return on Assets for Jazz Pharmaceuticals (JAZZ) over the last 17 years, with Q3 2025 value amounting to 0.02%.

  • Jazz Pharmaceuticals' Return on Assets fell 600.0% to 0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year decrease of 600.0%. This contributed to the annual value of 0.05% for FY2024, which is 100.0% up from last year.
  • According to the latest figures from Q3 2025, Jazz Pharmaceuticals' Return on Assets is 0.02%, which was down 600.0% from 0.03% recorded in Q2 2025.
  • Jazz Pharmaceuticals' 5-year Return on Assets high stood at 0.08% for Q1 2021, and its period low was 0.04% during Q1 2022.
  • Moreover, its 5-year median value for Return on Assets was 0.0% (2022), whereas its average is 0.01%.
  • In the last 5 years, Jazz Pharmaceuticals' Return on Assets tumbled by -1100bps in 2022 and then skyrocketed by 600bps in 2023.
  • Jazz Pharmaceuticals' Return on Assets (Quarter) stood at 0.03% in 2021, then rose by 24bps to 0.02% in 2022, then skyrocketed by 283bps to 0.04% in 2023, then increased by 25bps to 0.05% in 2024, then crashed by -153bps to 0.02% in 2025.
  • Its Return on Assets stands at 0.02% for Q3 2025, versus 0.03% for Q2 2025 and 0.05% for Q1 2025.